Marcin Wiącek

TL;DR: In this article , the authors evaluated the safety and outcomes of revascularization treatments in patients with acute ischemic stroke (AIS) and COVID-19 and found that patients with COVID19 had higher rates of intracranial bleeding complications and worse clinical outcomes than contemporaneous non-COVID19 patients receiving treatment.

TL;DR: The results suggest preservation in the stroke care of higher severity of disease through the first pandemic year and a global decline and shift to lower volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared to the prior year.

TL;DR: Stent retriever thrombectomy for the treatment of ischemic stroke is safe, provides high rate of recanalization and good clinical outcomes in the setting of large vessel occlusion.

TL;DR: Among AIS patients, in whom onset-to-arrival time allowed to initiate the endovascular procedure within 6h of symptom duration, 21% were eligible for MT treatment according to more and 33% to less restrictive criteria.